Resultats de la cerca - Adriano Piris

  • Mostrar 1 - 18 resultats de 18
Refinar resultats
  1. 1
    Atypical and malignant hidradenomas: a histological and immunohistochemical study

    Atypical and malignant hidradenomas: a histological and immunohistochemical study per Rosalynn M. Nazarian, Payal Kapur, Dinesh Rakheja, Adriano Piris, Lyn M. Duncan, Martín C. Mihm, Mai P. Hoang

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Potent Phagocytic Activity Discriminates Metastatic and Primary Human Malignant Melanomas: A Key Role of Ezrin

    Potent Phagocytic Activity Discriminates Metastatic and Primary Human Malignant Melanomas: A Key Role of Ezrin per Luana Lugini, Francesco Lozupone, Paola Matarrese, Cristina Funaro, Francesca Luciani, Walter Malorni, Licia Rivoltini, Chiara Castelli, Antonella Tinari, Adriano Piris, Giorgio Parmiani, Stefano Fais

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families

    Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families per Ching-Ni Jenny Njauw, Ivana K. Kim, Adriano Piris, Michele Gabree, Michael Taylor, Anne Marie Lane, Margaret M. DeAngelis, Evangelos S. Gragoudas, Lyn M. Duncan, Hensin Tsao

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes

    BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes per Zachary A. Cooper, Dennie T. Frederick, Vikram R. Juneja, Ryan J. Sullivan, Donald P. Lawrence, Adriano Piris, Arlene H. Sharpe, David E. Fisher, Keith T. Flaherty, Jennifer A. Wargo

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma

    Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma per Che-Hung Shen, Sun Hye Kim, Sebastian Trousil, Dennie T. Frederick, Adriano Piris, Ping Yuan, Li Cai, Lei Gu, Man Li, Jung‐Hyun Lee, Devarati Mitra, David E. Fisher, Ryan J. Sullivan, Keith T. Flaherty, Bin Zheng

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade

    Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade per Zachary A. Cooper, Vikram R. Juneja, Peter T. Sage, Dennie T. Frederick, Adriano Piris, Devarati Mitra, Jennifer A. Lo, F. Stephen Hodi, Gordon J. Freeman, Marcus Bosenberg, Martin McMahon, Keith T. Flaherty, David E. Fisher, Arlene H. Sharpe, Jennifer A. Wargo

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment

    Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment per Adam A. Friedman, Arnaud Amzallag, Iulian Pruteanu-Malinici, Subash Baniya, Zachary A. Cooper, Adriano Piris, Leeza Hargreaves, Vivien Igras, Dennie T. Frederick, Donald P. Lawrence, Daniel A. Haber, Keith T. Flaherty, Jennifer A. Wargo, Sridhar Ramaswamy, Cyril H. Benes, David E. Fisher

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of <i>BRAF</i>-Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

    EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of <i>BRAF</i>-Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib per Ryan B. Corcoran, Hiromichi Ebi, Alexa B. Turke, Erin M. Coffee, Michiya Nishino, Alexandria P. Cogdill, Ronald D. Brown, Patricia Della Pelle, Dora Dias‐Santagata, Kenneth E. Hung, Keith T. Flaherty, Adriano Piris, Jennifer A. Wargo, Jeffrey Settleman, Mari Mino‐Kenudson, Jeffrey A. Engelman

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma

    Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma per Gabriel J. Starrett, Manisha Thakuria, Tianqi Chen, Christina Marcelus, Jingwei Cheng, Jason Nomburg, Aaron R. Thorner, Michael K. Slevin, Winslow Powers, Robert Burns, Caitlin Perry, Adriano Piris, Frank C. Kuo, Guilherme Rabinowits, Anita Giobbie‐Hurder, Laura E. MacConaill, James A. DeCaprio

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    <i>RAS</i> Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors

    <i>RAS</i> Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors per Patrick A. Oberholzer, Damien Kee, Piotr Dziunycz, Antje Sucker, Nyam Kamsu-Kom, Robert T. Jones, Christine Roden, Clinton J. Chalk, Kristin Ardlie, Emanuele Palescandolo, Adriano Piris, Laura E. MacConaill, Caroline Robert, Günther F.L. Hofbauer, Grant A. McArthur, Dirk Schadendorf, Levi A. Garraway

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors

    A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors per David J. Konieczkowski, Cory M. Johannessen, Omar O. Abudayyeh, Jong Wook Kim, Zachary A. Cooper, Adriano Piris, Dennie T. Frederick, Michal Barzily-Rokni, Ravid Straussman, Rizwan Haq, David E. Fisher, Jill P. Mesirov, William C. Hahn, Keith T. Flaherty, Jennifer A. Wargo, Pablo Tamayo, Levi A. Garraway

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in <i>BRAF-</i> Mutant Melanoma

    TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in <i>BRAF-</i> Mutant Melanoma per Ryan B. Corcoran, S. Michael Rothenberg, Aaron N. Hata, Anthony C. Faber, Adriano Piris, Rosalynn M. Nazarian, Ronald D. Brown, Jason T. Godfrey, Daniel Winokur, John R. Walsh, Mari Mino‐Kenudson, Shyamala Maheswaran, Jeffrey Settleman, Jennifer A. Wargo, Keith T. Flaherty, Daniel A. Haber, Jeffrey A. Engelman

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation

    Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation per Hyungsoo Kim, Dennie T. Frederick, Mitchell P. Levesque, Zachary A. Cooper, Yongmei Feng, Clemens Krepler, Laurence M. Brill, Yardena Samuels, Nicholas K. Hayward, Ally Perlina, Adriano Piris, Tongwu Zhang, Ruth Halaban, Meenhard M. Herlyn, Kevin M. Brown, Jennifer A. Wargo, Reinhard Dummer, Keith T. Flaherty, Ze’ev A. Ronai

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma

    BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma per Dennie T. Frederick, Adriano Piris, Alexandria P. Cogdill, Zachary A. Cooper, Cecilia Lezcano, Cristina R. Ferrone, Devarati Mitra, Andrea Boni, Lindsay P. Newton, Chengwen Liu, Weiyi Peng, Ryan J. Sullivan, Donald P. Lawrence, F. Stephen Hodi, Willem W. Overwijk, Gregory Lizée, Gëorge F. Murphy, Patrick Hwu, Keith T. Flaherty, David E. Fisher, Jennifer A. Wargo

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming

    STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming per Zhaowei Chu, Lei Gu, Yeguang Hu, Xiaoyang Zhang, Man Li, Jiajia Chen, Da Teng, Man Huang, Che‐Hung Shen, Li Cai, Toshimi Yoshida, Yifeng Qi, Zhixin Niu, Austin Y. Feng, Songmei Geng, Dennie T. Frederick, Emma Specht, Adriano Piris, Ryan J. Sullivan, Keith T. Flaherty, Genevieve M. Boland, Katia Georgopoulos, David Liu, Yang Shi, Bin Zheng

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma

    Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma per R. Mark Simpson, Boris C. Bastian, Helen Michael, Joshua D. Webster, Manju L. Prasad, Catherine Conway, Víctor M. Prieto, Joy Gary, Michael H. Goldschmidt, D. Glen Esplin, Rebecca C. Smedley, Adriano Piris, Donald J. Meuten, Matti Kiupel, Chyi‐Chia Richard Lee, Jerrold M. Ward, Jennifer E. Dwyer, Barbara J. Davis, Miriam R. Anver, Alfredo Molinolo, Shelley Hoover, Jaime Rodriguez‐Canales, Stephen M. Hewitt

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Toward Minimal Residual Disease-Directed Therapy in Melanoma

    Toward Minimal Residual Disease-Directed Therapy in Melanoma per Florian Rambow, Aljosja Rogiers, Oskar Marín-Béjar, Sara Aibar, Julia Femel, Michael Dewaele, Panagiotis Karras, Daniel V. Brown, Young Hwan Chang, Maria Dębiec‐Rychter, Carmen Adriaens, Enrico Radaelli, Pascal Wolter, Oliver Bechter, Reinhard Dummer, Mitchell P. Levesque, Adriano Piris, Dennie T. Frederick, Genevieve M. Boland, Keith T. Flaherty, Joost van den Oord, Thierry Voet, Stein Aerts, Amanda W. Lund, Jean‐Christophe Marine

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    <i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

    <i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids per Russell W. Jenkins, Amir Reza Aref, Patrick H. Lizotte, Elena Ivanova, Susanna Stinson, Chensheng W. Zhou, Michaela Bowden, Jiehui Deng, Hongye Liu, Diana Miao, Meng Xiao He, William H. Walker, Gao Zhang, Tian Tian, Chaoran Cheng, Zhi Wei, Sangeetha Palakurthi, Mark Bittinger, Hans Vitzthum, Jong Wook Kim, Ashley A. Merlino, Max M. Quinn, Chandrasekar Venkataramani, Joshua A. Kaplan, Andrew Portell, Prafulla C. Gokhale, Bart Phillips, Alicia Smart, Asaf Rotem, Robert E. Jones, Lauren Keogh, María Anguiano, Lance Stapleton, Zhiheng Jia, Michal Barzily-Rokni, Israel Cañadas, Tran C. Thai, Marc R. Hammond, Raven Vlahos, Eric S. Wang, Hua Zhang, Shuai Li, Glenn J. Hanna, Wei Huang, Mai P. Hoang, Adriano Piris, Jean-Pierre Eliane, Anat Stemmer‐Rachamimov, Lisa Cameron, Mei-Ju Su, Parin Shah, Benjamin Izar, Manisha Thakuria, Nicole R. LeBoeuf, Guilherme Rabinowits, Viswanath Gunda, Sareh Parangi, James M. Cleary, Brian C. Miller, Shunsuke Kitajima, Rohit Thummalapalli, Benchun Miao, Thanh U. Barbie, Vivek Sivathanu, Joshua A. Wong, William G. Richards, Raphael Bueno, Charles H. Yoon, Juan J. Miret, Meenhard Herlyn, Levi A. Garraway, Eliezer M. Van Allen, Gordon J. Freeman, Paul T. Kirschmeier, Jochen H. Lorch, Patrick A. Ott, F. Stephen Hodi, Keith T. Flaherty, Roger D. Kamm, Genevieve M. Boland, Kwok‐Kin Wong, David Dornan, Cloud P. Paweletz, David A. Barbie

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: